The Priestley Medal was awarded to George A Olah
On Mar. 1, 2005, the American Chemical Society awarded the Priestley Medal to George A. Olah “to recognize…
-
-
The California Institute for Regenerative Medicine was established
In 2005, the California Institute for Regenerative Medicine (CIRM) was formally established following the passage of Proposition 71…
-
FDA approved Kepivance for severe oral mucositis in cancer patients undergoing bone marrow transplant
On Dec. 15, 2004, Amgen announced that following priority review, the FDA has approved Kepivance(TM) (palifermin), the first…
-
Biotechnology | Disease | FDA | Oncology | Therapeutics
Genentech drug Tarceva (erlotinib) was approved
On Nov. 18, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved Genentech’s drug Tarceva…
-
Touro University was founded
In 2004, Touro University Nevada (TUN), located in Henderson, was founded as a private, non-profit institution of higher…
-
The Scripps Research Institute announced the establishment of a major science center in Palm Beach County, Florida
On Oct. 9, 2003, The Scripps Research Institute (TSRI) announced the establishment of a major science center in…
-
Biotechnology | HIV | Infectious Disease | NIH | Vaccine
$81 million was awarded by NIAID through four new contracts to support development of candidate HIV vaccines
On Sept. 29, 2003, $81 million was awarded by National Institute of Allergy and Infectious Diseases (NIAID) through…
-
Biotechnology | Disease | FDA | Medicine | Therapeutics
Long-term efficacy and safety of etanercept was found in children with polyarticular-course juvenile rheumatoid arthritis
On Jan. 10, 2003, long-term efficacy and safety of etanercept (Enbrel) was found in children with polyarticular-course juvenile…
-
The Institute for Collaborative Biotechnologies was founded
In 2003, The Institute for Collaborative Biotechnologies (ICB) was founded as an Army-sponsored University Affiliated Research Center (UARC)….
-
Biotechnology | Disease | FDA
Genentech drug Pegasys (peginterferon alfa-2a) approved
On Dec. 3, 2002, Genentech drug Pegasys (peginterferon alfa-2a) was approved by the Food and Drug Administration (FDA)…
-
Stanford researchers became the first to use gene expression profiling to predict cancer outcomes
In 2002, Stanford researchers became the first to use gene expression profiling to predict cancer outcomes. The research…
-
The Nevada Cancer Institute was founded
In 2002, the Nevada Cancer Institute (NVCI), founded in 2002 and located in Summerlin, was a non-profit organization…
-
Biotechnology | FDA | Medicine | Therapeutics
The acquisition of Immunex by Amgen for $16 billion was announced
On Dec. 17, 2001, the acquisition of Immunex by Amgen was announced for $16 billion in stock and…
-
Stanford researchers identified a novel gene family involved in asthma
On Nov. 19, 2001, researchers at Lucile Packard Children’s Hospital at Stanford announced they had identified a novel…
-
Livermore National Lab announced partnership with BioLuminate to develop ‘Smart Probe’ for breast cancer detection
On Jan. 10, 2001, Livermore National Laboratory announced a partnership with BioLuminate to develop ‘Smart Probe’ tool for…
-
Moores Cancer Center at UC San Diego achieved NCI designated comprehensive cancer center status
In 1978, Moores Cancer Center (MCC) at UC San Diego achieved National Cancer Institute (NCI) designated comprehensive cancer…
-
Compulsive shopping research at Stanford seeks to treat mysterious disorder
On Dec. 16, 2002, researchers at Stanford University Medical Center announced they were continuing a multi-year clinical trial…
-
Genentech drug TNKase (tenecteplase) was approved
On June 2, 2000, the U.S. Food and Drug Administration announced it had approved Genentech’s drug TNKaseﾮ (tenecteplase)….
-
The Stanford Hospital Center for Clinical Sciences Research building opened
In 2000, the Center for Clinical Sciences Research building opened, and is an example of a fully integrated…
-
QB 3 was founded as the University of California’s hub for innovation and entrepreneurship in life science
In 2000, QB3 founded as the University of California’s hub for innovation and entrepreneurship in life science, with…
-
Stanford researchers first used gene expression profiling to distinguish cancer sub-types
In 2000, Stanford researchers led by Ash Alizadeh announced they had used gene expression profiling to identify two…
-
The University of California, Riverside Center for Nanoscale Science and Engineering was established
In 2000, the University of California, Riverside Center for Nanoscale Science and Engineering was established to capitalize on…
-
The Norris Foundation committed $15 million toward construction of the Harlyne J Norris Research Tower
On Jan. 10, 2012, the Norris Foundation made a $15 million commitment toward construction of the Harlyne J….
-
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
UCSF Cancer Research Institute received NCI Comprehensive Cancer Center designation
In 1999, University of California at San Francisco Cancer Research Institute received NCI Comprehensive Cancer Center designation. The…
-
Biotechnology | Diagnostics | Genomics | NIH | Therapeutics
Livermore National Lab work was completed on the mouse genome as part of Laboratory efforts in comparative genomics
On Oct. 30, 1999, Livermore National Lab work completed work on the mouse genome as part of Laboratory…
-
The Del E. Webb Center for Neuroscience and Aging was established at The Burnham Institute
In 1999, the Del E. Webb Center for Neuroscience and Aging, which focuses on diseases such as stroke,…
-
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics | Women's Health
The FDA approved the monoclonal antibody Herceptin (Trastuzumab) for treatment of metastatic breast cancer
On Sept. 25, 1998, the U.S. Food and Drug Administration (FDA) approved the monoclonal antibody Herceptin (Trastuzumab) for…
-
Biotechnology | FDA | Oncology | Therapeutics
The FDA approved Genentech drug Xeloda (capecitabine)
On April 30, 1998, the U.S. Food and Drug Administration (FDA) approved the Genentech’s drug Xeloda (capecitabine) for…
-
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
The City of Hope Cancer Center received NCI comprehensive cancer center designation
In 1998, National Cancer Institute (NCI) awarded the City of Hope Cancer Center NCI-comprehensive cancer center designation. City…
-
The Norris Comprehensive Cancer Center received a $5 million gift from local philanthropist Henrietta Lee
In 1998, The Norris Comprehensive Cancer Center received a $5 million gift from local philanthropist Henrietta Lee which…
